HEALTH

NIH joins patent pool for AIDS drugs

IBTimes Logo
The United States National Institutes of Health said on Thursday it will share intellectual property rights on some AIDS drugs in a patent pool designed to make treatments more widely available to the poor.
More news
IBTimes Logo

Less costly home dialysis just as effective

Patients with failing kidneys who need to undergo dialysis will do equally well if they perform dialysis at home or if they go to a dialysis center, according to the largest study to date comparing the two approaches.
IBTimes Logo

Magnetic pulses can sway the hand you use, briefly

Whether your left or right hand reaches for the phone, elevator button or cup of coffee is typically decided unconsciously. Now, a new study suggests that magnetic pulses sent into your brain could alter that choice.
IBTimes Logo

Obama administration fights for stem cell funding

The Obama administration on Monday pleaded with a U.S. appeals court to allow federal funding of human embryonic stem cell research to continue, arguing a ban would ruin numerous projects and cost millions of dollars.
IBTimes Logo

Exercise has lasting benefits for older women

Older women with thinning bones who exercise regularly have sustained improvements in their balance and walking speed that may protect them from fractures and even extend their lives, new research shows
IBTimes Logo

Middle-aged suicides on rise in U.S., study finds

Suicide rates for middle-aged people are edging up -- particularly for white men without college degrees -- and a combination of poor health and a poor economy may be driving it, U.S. researchers said on Monday.
IBTimes Logo

Employer health costs to rise in 2011

Employers can expect to pay nearly 9 percent more for health care costs for their workers in 2011, the highest level in five years, according to a forecast released on Monday.
IBTimes Logo

Sanofi says holds offer for Genzyme at $69/share

Sanofi-Aventis has not changed its offer of $69 per share for drugmaker Genzyme, a Sanofi spokesman said Monday, declining to comment on a report that the drugmaker had lined up more financing for its bid.
IBTimes Logo

Genetic discovery could lead to brain treatments

British scientists have discovered a genetic mechanism in the development of the nervous system that they say might one day be part of new treatments for stroke, Alzheimer's disease or brain tumors.
IBTimes Logo

More aid needed to fight child hunger in Chad: U.N

Up to a quarter of children in parts of Chad are facing acute hunger despite an easing of the overall famine threat across the Sahel region of Africa, UNICEF warned on Friday, calling on donors to provide more funds.
IBTimes Logo

ADHD drug benefits child cancer survivors

Children who develop problems with memory, attention and behavior after cancer treatment may gain some long-term benefit from a medication commonly used for attention-deficit hyperactivity disorder (ADHD), a small clinical trial suggests.
IBTimes Logo

Did doctors jumpstart the HIV pandemic?

Perhaps it wasn't sex workers and fast-growing cities that launched HIV onto its deadly global rampage, but well-meaning doctors using dirty needles in the first half of the 20th century.
IBTimes Logo

Amgen, J&J anemia drugs recalled over glass flakes

Amgen Inc is recalling several hundred lots of anemia drugs Epogen and Procrit, sold by Johnson & Johnson, because vials of the injectable medicines might develop tiny glass flakes that could cause blood clots and other serious health problems.
IBTimes Logo

Did doctors jump start the HIV pandemic?

Perhaps it wasn't sex workers and fast-growing cities that launched HIV onto its deadly global rampage, but well-meaning doctors using dirty needles in the first half of the 20th century.
IBTimes Logo

Group proposes health insurers' spending rules

Health insurers should be able to exclude most federal taxes, but not all, in calculating spending rates to meet new healthcare law requirements, an insurance advisory group has proposed.
IBTimes Logo

Abbott identifies recalled baby formula lots

Abbott Laboratories posted a list of lot numbers on Thursday for the millions of recalled containers of its Similac powdered infant formulas and expanded Internet and call center capacity to handle a deluge of requests for information from concerned parents.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.